Role of CD8 regulatory T-cells in multiple sclerosis. 2011

Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D050378 T-Lymphocytes, Regulatory CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells. Regulatory T Cell,Regulatory T-Cell,Regulatory T-Lymphocyte,Regulatory T-Lymphocytes,Suppressor T-Lymphocytes, Naturally-Occurring,T-Cells, Regulatory,Th3 Cells,Tr1 Cell,Treg Cell,Regulatory T-Cells,Suppressor T-Cells, Naturally-Occurring,Tr1 Cells,Treg Cells,Cell, Regulatory T,Cell, Th3,Cell, Tr1,Cell, Treg,Cells, Regulatory T,Cells, Th3,Cells, Tr1,Cells, Treg,Naturally-Occurring Suppressor T-Cell,Naturally-Occurring Suppressor T-Cells,Naturally-Occurring Suppressor T-Lymphocyte,Naturally-Occurring Suppressor T-Lymphocytes,Regulatory T Cells,Regulatory T Lymphocyte,Regulatory T Lymphocytes,Suppressor T Cells, Naturally Occurring,Suppressor T Lymphocytes, Naturally Occurring,Suppressor T-Cell, Naturally-Occurring,Suppressor T-Lymphocyte, Naturally-Occurring,T Cell, Regulatory,T Cells, Regulatory,T Lymphocytes, Regulatory,T-Cell, Naturally-Occurring Suppressor,T-Cells, Naturally-Occurring Suppressor,T-Lymphocyte, Regulatory,Th3 Cell
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
May 2010, Annals of neurology,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
January 2010, Medicina,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
March 2008, Journal of neuroimmunology,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
June 2006, Journal of immunology (Baltimore, Md. : 1950),
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
July 2008, Nature clinical practice. Neurology,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
September 2013, Expert opinion on therapeutic targets,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
August 2009, Annals of neurology,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
November 2022, Neurology(R) neuroimmunology & neuroinflammation,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
February 2021, The New England journal of medicine,
Karim L Kreft, and Evert Verbraak, and Annet F Wierenga-Wolf, and Jon D Laman, and Rogier Q Hintzen
January 2021, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!